Accelera
Accelera is a premium tier Contract Research Organization (CRO) specializing in preclinical research and drug development. With decades of experience in the pharmaceutical field, it collaborates with over 300 pharmaceutical and biotechnology companies worldwide. The company offers customized services across all phases of drug research, including toxicology, safety pharmacology, regulatory support, and more. It is committed to high-quality, effective, and fast results, supporting the development of new chemical entities, biologics, oncology drugs, and therapies, while maintaining compliance with international guidelines.
Industries
Nr. of Employees
medium (51-250)
Services
Contract execution of general toxicology studies to assess systemic toxicity and support preclinical development.
Design and conduct of reproductive and developmental toxicology studies for regulatory submissions.
Nonclinical safety pharmacology testing to evaluate effects on vital organ systems.
Regulatory consultancy and support for preparation of submission packages and compliance with international regulatory agencies.
Execution of ADME and PK/PD studies combined with PBPK and PK/PD modelling to support dose selection and translation.
Synthesis of radiolabeled compounds for ADME, biodistribution and tracer studies.
Contract execution of general toxicology studies to assess systemic toxicity and support preclinical development.
Design and conduct of reproductive and developmental toxicology studies for regulatory submissions.
Nonclinical safety pharmacology testing to evaluate effects on vital organ systems.
Regulatory consultancy and support for preparation of submission packages and compliance with international regulatory agencies.
Execution of ADME and PK/PD studies combined with PBPK and PK/PD modelling to support dose selection and translation.
Synthesis of radiolabeled compounds for ADME, biodistribution and tracer studies.
Expertise Areas
- Preclinical toxicology and safety assessment
- Reproductive and developmental toxicology
- Safety pharmacology
- ADME and PK/PD characterization
Key Technologies
- In vivo toxicology models
- In vitro bioassays
- ADME assays
- PBPK modelling